Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Retained Earnings (2016 - 2026)

MedWellAI has reported Retained Earnings over the past 11 years, most recently at -$89.6 million for Q4 2025.

  • Quarterly Retained Earnings fell 3.06% to -$89.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$89.6 million through Dec 2025, down 3.06% year-over-year, with the annual reading at -$88.7 million for FY2025, 4.24% down from the prior year.
  • Retained Earnings was -$89.6 million for Q4 2025 at MedWellAI, roughly flat from -$89.3 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $87.5 million in Q1 2025 and troughed at -$89.6 million in Q4 2025.
  • The 5-year median for Retained Earnings is -$61.9 million (2023), against an average of -$58.5 million.
  • Year-over-year, Retained Earnings plummeted 104.29% in 2021 and then soared 205.88% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$44.5 million in 2021, then decreased by 9.39% to -$48.7 million in 2022, then tumbled by 70.28% to -$82.9 million in 2023, then dropped by 4.88% to -$87.0 million in 2024, then fell by 3.06% to -$89.6 million in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Retained Earnings are -$89.6 million (Q4 2025), -$89.3 million (Q3 2025), and -$88.7 million (Q2 2025).